DUQYNZO
Live / Applied — Fourth extension granted (statement of use) (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 06 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98166780
- Mark type
- Stylized text
- Filed
- 06 Sept 2023
- Published for opposition
- 20 Feb 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
- Class 042 — Scientific and technological services: pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Owner
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
Prosecution history
- 21 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2026 — SOU EXTENSION 4 GRANTED
- 20 Mar 2026 — SOU EXTENSION 4 FILED
- 20 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Sept 2025 — SOU EXTENSION 3 GRANTED
- 22 Sept 2025 — SOU EXTENSION 3 FILED
- 22 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2025 — SOU EXTENSION 2 GRANTED
- 20 Mar 2025 — SOU EXTENSION 2 FILED
- 20 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Sept 2024 — SOU EXTENSION 1 GRANTED
- 13 Sept 2024 — SOU EXTENSION 1 FILED